It’s one step closer to being pulled from the market:
Barbara Ryan, an analyst for Deutsche Bank Securities, said that the agency’s report ensures that “there are going to be a lot of lawsuits.” She noted that some firms were already advertising for clients.
Related posts:
- Avandia: A "flood" of lawsuits is coming
- Merck’s prevailing Vioxx strategy
- Avandia pulled from the VA formulary
- A reprieve for Avandia
- Does Avandia cause heart attacks, and why the RECORD study is important
- Avandia, MI, and cardiac death
- Mark Lanier on Avandia
KevinMD.com on Facebook
Scrubs
Comments on this entry are closed.